Skip to main content
Kim Peaslee

Kimberly Peaslee , PhD

Special Advisor | US Patent and Trademark Fasken
Jurisdiction Massachusetts, 2010 | United States, 2008
Language(s) English
Office(s) Montréal
Contact
Share
  • LinkedIn

Overview

Kimberly Peaslee is a registered US Patent and Trademark Attorney working out of our Montréal office. Kimberly brings a unique combination of scientific depth and legal experience to help clients protect and maximize the value of their innovations and their brands. She earned a Ph.D. in Biophysical Chemistry from Dartmouth College after graduating with a B.A. in Chemistry, cum laude, from the University of Southern Maine. Her passion for advancing innovation led her to pursue a law degree, cum laude, at Franklin Pierce Law Center.

Kimberly began her legal career as a Merck Patent Fellow, where she gained hands-on experience in pharmaceutical patent prosecution. She has worked on Technology licensing, IP due diligence, IP litigation support, and IP Portfolio Management. Kimberly has worked on a diverse range of technologies including pharmaceuticals (small molecules and biologics); polymers, coatings, and materials; optics; communications; medical and mechanical devices; and consumer products. Her clients range from entrepreneurs to established corporations and universities. She enjoys developing tailored IP strategies that foster growth and protect competitive advantage. Her scientific background combined with her legal training allows her to navigate complex technologies and deliver practical, business-focused solutions.

Kim works closely with innovators, researchers, and businesses to navigate the complexities of intellectual property, providing practical and customized solutions that support growth and competitiveness.

Career & Education

Education

  • JD, Cum laude University of New Hampshire
  • Ph. D., Biophysical Chemistry Dartmouth College
  • BA, Chemistry | Cum laude University of Southern Maine

Events

Publications

  • Toward Rational Design of Species-Specific Inhibitors of Pneumocystis carinii Thymidylate Synthase and Toxoplasma gondii Dihydrofolate Reductase-Thymidylate Synthase, 7/11/2005
  • Toxoplasma gondii: generation of novel truncation mutations in the linker domain of dihydrofolate reductase-thymidylate synthase, 1/1/2004
  • Enhanced photoluminescence from group 14 metalloles in aggregated and solid solutions, 3/1/2003